-
公开(公告)号:AT64300T
公开(公告)日:1991-06-15
申请号:AT87115417
申请日:1987-10-21
Applicant: BASF AG
IPC: A61K31/275 , A61K31/277 , A61P35/00
-
公开(公告)号:AT45674T
公开(公告)日:1989-09-15
申请号:AT86113453
申请日:1986-10-01
Applicant: BASF AG
IPC: A61K31/60 , A61K31/275 , A61K31/277 , A61P7/02 , A61K31/615
-
公开(公告)号:DE3770766D1
公开(公告)日:1991-07-18
申请号:DE3770766
申请日:1987-10-21
Applicant: BASF AG
IPC: A61K31/275 , A61K31/277 , A61P35/00
Abstract: Products containing on the one hand (+)-verapamil, (+)-gallopamil, (+)-devapamil and/or (+)-emopamil, and on the other hand a carcinostatic as combination product for concurrent, separate or sequential administration in cytostatic therapy are described.
-
公开(公告)号:DE3665126D1
公开(公告)日:1989-09-28
申请号:DE3665126
申请日:1986-10-01
Applicant: BASF AG
IPC: A61K31/60 , A61K31/275 , A61K31/277 , A61P7/02 , A61K31/615
Abstract: A combination of verapamil, gallopamil or anipamil and acetylsalicylic acid in a weight ratio of from 10:1 to 2:1 being useful in the treatment of circulatory disorders.
-
-
-